No Picture
Stocks List

Burcon NutraScience Corp

Burcon NutraScience Corp

Burcon NutraScience Is on The Verge of Further Surge

Burcon NutraScience Corp is a Canada company, which is engaged in development of functional and renewable plant proteins. The company has a market cap of $90.30 million. The Firm has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology. It currently has negative earnings. The Firm and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates.

The company’s share price continues to be

Read More
No Picture
Stocks List

Capstone Infrastructure (CPA)

Capstone Infrastructure (CPA)

Capstone Infrastructure is Heading in the Right Direction

Capstone Infrastructure (CPA) mission is to provide investors with an attractive total return from responsibly managed long-term investments in core infrastructure in Canada and internationally. The company’s strategy is to develop, acquire and manage a portfolio of high quality utilities, power and transportation businesses, and public-private partnerships that operate in a regulated or contractually-defined environment and generate stable cash flow.

Capstone at present has interests in utilities organizations in Europe and claims, works and creates warm and renewable power era offices in Canada with an aggregate introduced limit of

Read More
No Picture
Stocks List

Canadian Solar (NASDAQCSIQ)

Canadian Solar (NASDAQCSIQ)

Canadian Solar Looks Undervalued

Canadian Solar (NASDAQ:CSIQ) has tumbled from around $40 to around $11 since the second quarter of 2015. It hit a 52-week low at $11.72 on Sept. 16, 2016 (down from a high of $29.83). According to Canadian Solar’s site, in the previous 14 years, the organization has effectively conveyed more than 16 GW of premium quality modules to more than 90 nations around the globe. Besides, Canadian Solar is a standout amongst the most bankable organizations in the solar based industry, having been freely recorded on the Nasdaq since 2006.

2014 was an

Read More
No Picture
Penny Stocks Articles

Calpine (CPN) n

Calpine (CPN) n

Calpine is a Volatile Stock

Calpine (NYSE:CPN) is in an intriguing spot. It may be that whatever happens, it can’t generally ever win. At any rate not by much. Appropriately organized it can’t lose, either, yet that is irrelevant, as not winning expels upside situations. This article will clarify why.

Calpine is an autonomous power maker/discount control era organization. Its armada comprises overwhelmingly of regular gas let go turbines. In rearranged terms, Calpine purchases characteristic gas, smolders it in its turbines to create power, and offers the power into a discount control advertise.

In the discount control

Read More
No Picture
Penny Stocks Articles

By year-end, Inovio Pharmaceuticals (NYSEMKT:INO)

By year-end, Inovio Pharmaceuticals (NYSEMKT:INO)

By year-end, Inovio Pharmaceuticals (NYSEMKT:INO) hopes to dispatch or write about four clinical trials for its DNA antibodies and treatments; any or all could be close term stock impetuses, if fruitful – or stock deflators, if not. Here they are, with potential income situations: VGX-3100: Cervical dysplasia treatment, INO-5150: Prostate disease treatment, Zika immunization and MERS antibody.

The VGX-3100 medication hopeful has by a long shot the best potential quality to Inovio. The income possibilities for the other three hopefuls could not hope to compare, because of sovereignty just incomes, one-time organization to a settled

Read More
No Picture
Penny Stocks Articles

Buy Ariad For Big Profits

Buy Ariad For Big Profits

Recently, Ariad declared that it had started a moving NDA accommodation to the FDA, with the desires of increasing quickened endorsement for brigatinib. Presently, ARIA has finished its accommodation, which will begin the clock on a choice by the FDA.

The organization asked for need survey for brigatinib in patients with crizotinib-safe lung tumor. Considering they’ve gotten achievement treatment assignment in this setting, it appears to be sensible the FDA will submit.

Need survey would shave 4 months off the FDA’s course of events to give a reaction, bringing the aggregate cost down to 8

Read More
No Picture
Stocks List

Carrizo Oil and Gas

Carrizo Oil and Gas

Carrizo Oil and Gas hopes to concentrate more on the oil a portion of its name than the gas part later on. Carrizo is principally packing its improvement in the Eagle Ford Shale which has oil creation parts in the mid-70s contrasted with Carrizo’s general 58% oil generation. This will build its oil rate after some time.

Its outstanding shares are at 58.974 M, while authorized shares at 90,000,000.

Solid results from Carrizo’s Eagle Ford Shale resources joined with expanded capital consumption direction have added to Carrizo expanding its 2016 production direction. The greater part of

Read More
No Picture
Stocks List

BPZ Resources, Inc (BPZ)

BPZ Resources, Inc (BPZ)

As already declared, on November 12, 2015, the Bankruptcy Court entered a request affirming the Company’s Second Amended Plan of Liquidation and Second Amended Disclosure Statement. On December 31, 2015, all conditions to the event of the viable date put forward in the Plan and the Confirmation Order were fulfilled or deferred in agreement therewith and the powerful date of the Plan happened.

On the same date, BPZ Resources, Inc (BPZ) recorded a Notice of Effective Date of the Plan with the Bankruptcy Court.

As per the Plan, the greater part of the Company’s advantages have

Read More
No Picture
Penny Stocks Articles

CannaGrow Holdings Inc (OTCMKTS:CGRW)

CannaGrow Holdings Inc (OTCMKTS:CGRW)

CannaGrow Holdings Inc (OTCMKTS:CGRW) is one pot stock that can possibly make a solid upside surge. Its stock price made a major climb back in March, however kept running into resistance barely short of the $1 mark. Presently for more than two months, its stock has solidified in a tight range and wants to break out to the upside.

Its outstanding shares are standing around 102,073,434, while authorized shares at 300,000,000.

CannaGrow has entered the Medical/Recreational Cannabis Industry as a Liaison, and Consultant to authorized growers furnishing them with turnkey Growing Facilities in the State of

Read More
No Picture
Penny Stocks Articles

Banx Capital Adopts BitShares 2.0 Block Chain Backbone

BitShares and Banx Capital Announce Partnership

BitShares has announced a new partnership with #9 ranked cryptocurrency BanxShares backed by Banx Capital Ltd. In this partnership, Banx Capital and BanxShares will run on the BitShares 2.0 technology developed and licensed by Cryptonomex, a company started by the core development team and other key personnel within the BitShares entity. There are a a lot of great bit coin penny stocks. Make sure you check out our penny stocks page.

When asked why the #9 cryptocurrency would partner with the #5 cryptocurrency (as listed on CoinMarketCap.com), Banx Capital Founder & CEO Mark … Read More

No Picture
Stocks List

Awareness

Because of our huge loyal following, continuous outreach, and Great reputation we are able to provide investor awareness for publicly traded companies. We are very picky with which companies we bring awareness to. We do not run promotions like other fly by night promoters do who don’t care about their followers. If you believe you have a solid company and have a promising future feel free to get in contact with us. We will take you through an interview process.

Contact Us

Read More

No Picture
Penny Stocks Articles

Arena Pharmaceuticals (NASDAQARNA)

Arena Pharmaceuticals (NASDAQARNA)

Arena Pharmaceuticals Beats The Street: What Next

Arena Pharmaceuticals (NASDAQ:ARNA) beat the Street by $0.02 in the third quarter. The organization posted a loss of $12.4 million or $0.05 per share. New administration kept the call exceptionally short and with that curtness did not present much in the method for news. It ought to be perfectly clear now that Arena is centered around the pipeline and that Belviq has basically been removed from any spotlight.
Income from Belviq deals was just $3.3 million. This is down from $4.26 million in Q2 of this current year and down

Read More
No Picture
Stocks List

Arcadia Biosciences, Inc. (NASDAQ:RKDA)

Arcadia Biosciences, Inc. (NASDAQ:RKDA)

Arcadia Biosciences Tumbling, Keep an Eye on This Stock

Financial specialists have been inquiring about shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) after the stock moved – 0.58%, hitting the $1.70 value point taking after an exchange. Over the previous year, Arcadia Biosciences, Inc’s. stock was – up 43.75%. In the course of the most recent seven days of the month, it was – 11.40%, -23.66% over the three months, and -32.68% for the past half-year.

Arcadia Biosciences, Inc., incorporated on February 17, 2015, is an agricultural biotechnology trait company. The Firm develops a portfolio of yield

Read More
No Picture
Stocks List

Aoxin Tianli Group Looks like A Solid Penny Stock

Aoxin Tianli Group Looks like A Solid Penny Stock

Aoxin, before now known as Tianli Agritech, was initially just a hog cultivating organization situated in Wuhan City, China. Be that as it may, in the course of the last couple of years it has started to enhance its business. The organization now views itself as a broadened business with numerous working portions that have close to nothing or nothing to do with each other.

It as of now claims to work in the hog cultivating, electro-pressure driven servo-valves assembling and advertising, and optical fiber equipment and programming arrangements organizations. The

Read More
No Picture
Penny Stocks Articles

Ballard Power Systems Inc. (NASDAQBLDP)

Ballard Power Systems Inc. (NASDAQBLDP)

Ballard Power Systems Could Make a rebound

Established in the mid 90’s Ballard Power Systems Inc. (NASDAQ:BLDP) is a Canadian organization which concentrates on creating zero-emanation energy component innovation. Ballard Power has become the world pioneer in proton trade film hydrogen energy unit innovation and is hoping to ride out the present “green wave” among numerous modern countries.

Ballard Power’s innovation carries with it an extensive variety of use yet the territory which is gathering the most measure of consideration is in how the innovation can apply to the car part. This spots Ballard Power

Read More
No Picture
Stocks List

Ascent Solar (NASDAQASTI)

Ascent Solar (NASDAQASTI)

Ascent Solar Have Massive Outstanding Shares

Ascent Solar (NASDAQ:ASTI) has for quite some time been an agitated organization with a background marked by stupendous weakening. From average deals development to negative gross edges (the organization’s 2015 cost of incomes was 44% higher than their aggregate incomes), plainly the organization’s plan of action is profoundly defective.

However with Q3 reporting practically around the bend, I anticipate tending to the obvious issue at hand. This is the persevering and correctional weakening that Ascent Solar exacts upon its shareholders.

In the previous two years since the organization chose to move

Read More
No Picture
Penny Stocks Articles

Axcelis Technologies (NASDAQ:ACLS)

Axcelis Technologies (NASDAQ:ACLS)

Axcelis Technologies is an Innovative Company

Anybody paying consideration on Axcelis Technologies (NASDAQ:ACLS) realizes that administration has turned the organization around from an item and money related point of view. The organization’s business prospects have been changed in the wake of creating and presenting the Purion stage of particle embed devices in the course of recent years.

The organization’s accounting report is boundlessly enhanced after a deal leaseback exchange executed in January 2015 that additional $49 million in real money to the monetary record. Taken a toll cutting and streamlining has brought down expenses and enhanced edges

Read More
No Picture
Stocks List

Applied DNA Sciences, Inc. (NASDAQ: APDN)

Applied DNA Sciences, Inc. (NASDAQ: APDN)

Applied DNA Sciences Continues to Make a Progress

Applied DNA Sciences, Inc. (NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions.

The company become further rooted in the cotton supply chain, and demand for its SigNature T solution aligns with the industry’s seasonality that is cantered on the ginning season running from September through January, the grade of demand has altered comparative to last season. Its third quarter reflects lower-than-anticipated revenues.

Its late request to stamp 10 million pounds of Acala cotton, a market section

Read More
No Picture
Stocks List

Biospecifics Technologies Corp. (NASDAQ:BSTC)

Biospecifics Technologies Corp. (NASDAQ:BSTC)

Biospecifics Technologies Corp. (NASDAQ:BSTC) is a microcap stock that exchanges on the NASDAQ. The organization is in the biopharmaceutical segment and as of now gets revenue from its item known as XIAFLEX in the United States, Canada and Australia, and under the name of XIAPEX in Europe.

The item XIAFLEX/XIAPEX is an injectable collagenase utilized as a part of the treatment of a wide range of sicknesses. It principally treats conditions identifying with fibromatosis. In English, fibromatosis alludes to benevolent yet forceful delicate tissue tumors that hinder the development of a joint, and are regularly reoccurring.

Read More
No Picture
Stocks List

Array BioPharma Inc. (ARRY:NASDAQ)

Array BioPharma Inc. (ARRY:NASDAQ)

Array BioPharma Inc. (ARRY:NASDAQ) has a market of $565M. This firm is working on late-stage clinical programs with modest expectations. Array’s binimetinib is currently being developed for ovarian cancer and melanomas, but combinations provide for a long-lived pipeline. An ex-US partnership is expected.

Array BioPharma’s mix win in melanoma puts it financially behind, however maybe clinically in front of, Novartis (NYSE:NVS) and Roche (OTCQX:RHHBY). Movement free survival of 14.9 months for the binimetinib and encorafenib doublet is numerically superior to that of advertised contenders from the two Swiss gatherings, yet the littler biotech will come late

Read More